Impact of Prevention of DEpression in Patients with Acute Coronary Syndrome on CARDiac risk profile (DECARD): A double-blind, placebo-controlled study of escitalopram

International Journal of Cardiology ◽

10.1016/j.ijcard.2007.03.038 ◽

2007 ◽

Vol 119 ◽

pp. S14-S15

Author(s):

Jamal A. Hanash

Keyword(s):

Acute Coronary Syndrome ◽

Cardiac Risk ◽

Risk Profile ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome

Download Full-text

Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: Results of a randomized, double-blind, placebo-controlled study

American Heart Journal ◽

10.1016/j.ahj.2004.07.041 ◽

2005 ◽

Vol 149 (3) ◽

pp. 451-457 ◽

Author(s):

Stella M. Macin ◽

Eduardo R. Perna ◽

Eduardo F. Farías ◽

Valeria Franciosi ◽

Jorge R. Cialzeta ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome ◽

Anti Inflammatory ◽

Inflammatory Effect

Download Full-text

Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome

American Heart Journal ◽

10.1016/j.ahj.2011.01.026 ◽

2011 ◽

Vol 161 (5) ◽

pp. 815-821.e6 ◽

Author(s):

C. Michael Gibson ◽

Jessica L. Mega ◽

Paul Burton ◽

Shinya Goto ◽

Freek Verheugt ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Standard Therapy ◽

Cardiovascular Events ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome

Download Full-text

A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome

Atherosclerosis ◽

10.1016/j.atherosclerosis.2015.02.027 ◽

2015 ◽

Vol 240 (1) ◽

pp. 53-60 ◽

Author(s):

Juan Gaztanaga ◽

Michael Farkouh ◽

James H.F. Rudd ◽

Tilmann M. Brotz ◽

David Rosenbaum ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Vascular Inflammation ◽

Controlled Study ◽

Phase 2 ◽

Lipoxygenase Inhibitor ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome

Download Full-text

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)

Trials ◽

10.1186/1745-6215-10-20 ◽

2009 ◽

Vol 10 (1) ◽

Author(s):

Baiba Hedegaard Hansen ◽

Jamal Abed Hanash ◽

Alice Rasmussen ◽

Jørgen Fischer Hansen ◽

Morten Birket-Smith

Keyword(s):

Acute Coronary Syndrome ◽

Controlled Study ◽

Double Blind ◽

Coronary Syndrome

Download Full-text

Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)

Trials ◽

10.1186/1745-6215-11-61 ◽

2010 ◽

Vol 11 (1) ◽

Author(s):

Petr Ostadal ◽

David Alan ◽

Jiri Vejvoda ◽

Jiri Kukacka ◽

Milan Macek ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome ◽

First Line Therapy ◽

Download Full-text

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study

Cardiology Journal ◽

10.5603/cj.a2021.0056 ◽

2021 ◽

Author(s):

Jacek Kubica ◽

Piotr Adamski ◽

Piotr Niezgoda ◽

Aldona Kubica ◽

Przemysław Podhajski ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Study ◽

Antiplatelet Therapy ◽

Double Blind ◽

New Approach ◽

Double Blind Placebo ◽

Coronary Syndrome ◽

Multicenter Clinical Study

Download Full-text

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

European Heart Journal ◽

10.1093/eurheartj/ehr334 ◽

2011 ◽

Vol 32 (20) ◽

pp. 2541-2554 ◽

Author(s):

Ph. Gabriel Steg ◽

Shamir R. Mehta ◽

J. Wouter Jukema ◽

Gregory Y.H. Lip ◽

C. Michael Gibson ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Controlled Trial ◽

Factor Xa ◽

Factor Xa Inhibitor ◽

The Novel ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome

Download Full-text

A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Study of the Effects of Tongxinluo Capsules in Acute Coronary Syndrome Patients with High On-Treatment Platelet Reactivity

Chinese Medical Journal ◽

10.4103/0366-6999.226064 ◽

2018 ◽

Vol 131 (5) ◽

pp. 508-515 ◽

Author(s):

Lei Zhang ◽

Yi Li ◽

Bai-Song Yang ◽

Lu Li ◽

Xiao-Zeng Wang ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Platelet Reactivity ◽

Controlled Study ◽

Double Blind ◽

Coronary Syndrome

Download Full-text

Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the I f Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome—RIVIERA Trial Study Design and Rationale

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-009-6164-9 ◽

2009 ◽

Vol 23 (3) ◽

pp. 243-247 ◽

Author(s):

Alberto Dominguez-Rodriguez ◽

Sima Samimi Fard ◽

Pedro Abreu-Gonzalez ◽

Francisco Bosa-Ojeda ◽

Luciano Consuegra-Sanchez ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Study Design ◽

Controlled Trial ◽

Inflammation Markers ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome

Download Full-text

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

10.1016/s0140-6736(08)60763-1 ◽

2008 ◽

Vol 371 (9626) ◽

pp. 1761-1768 ◽

Author(s):

Jean-Claude Tardif ◽

John JV McMurray ◽

Eric Klug ◽

Robert Small ◽

Jennifer Schumi ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome

Download Full-text